Virtual Skin Model Reveals Secrets of Skin Aging

Engineers and biologists at the University of Sheffield have shown how a recent theory - that skin has 'sleeping' stem cells which can be woken up when required - best explains how our skin constantly regrows. The research - conducted in collaboration with The Procter & Gamble Company (P&G), makers of Olay, and published in Nature Scientific Reports - has implications for combating the effects of aging and perhaps even skin cancer.

The Sheffield/P&G team developed an "in silico" (computer) model of human skin biology, capturing how the outer layers of the skin are developed and maintained over time. This model simulation or "virtual" skin was then used to test the three most popular theories of how skin cells function to regenerate our skin, the largest human organ, over a three-year period. When the simulation was run according to two of the theories, the virtual skin failed to fully regenerate. Only one theory enabled the virtual skin to still be in good shape after three years, as Dr. Xinshan Li (University of Sheffield Faculty of Engineering) and Dr. Arun Upadhyay (P&G), the lead co-authors explained in their research.

"The theory which seems to fit best says that skin has a population of 'sleeping' stem cells, which sit in the lowest layer of the skin but don't constantly divide to make new cells," Dr. Li said. "However, these sleeping cells can be called into action if the skin is damaged, or if the numbers of other types of more mature skin cells decrease, ensuring that the skin can be constantly regenerated under all conditions."

The model showed that we gradually lose these sleeping stem cells over time - which would explain why our ability to regenerate our skin reduces as we age. "Each time we wake up these cells, to heal a wound or replenish stocks of other cells, a few of them don't go back into sleep mode, so the population slowly reduces," says Dr. Li. "This explains why older skin is slower to heal and in part why our skin changes as we age. By understanding this mechanism better, it might be possible to find ways to combat the effects of aging on our skin."

Computer modelling of skin biology is the latest step in the evolution of skin science. It allows scientists to project the activity of tissues like skin that are difficult to follow in live systems for extended periods. Currently, 3-dimensional cultures of engineered human skin are viable for only a few weeks and clinical studies in humans are only practical for a few months. With the development of in silico models scientists can predict for the first time what happens in skin as it ages year by year even as it ages decade by decade.

"These models permit exploration of hypotheses in very short periods of time, relative to the lab based bench work," says Dr. Upadhyay. "In silico modelling can significantly shorten R&D programs, and help focus subsequent lab or clinical work on the options with the greatest likelihood of succeeding. This is another reason why in silico models are an effective complement to more established research tools and methods."

The ability to follow virtual skin models over decades may be especially important to skin cancer research. Environmental damage caused by UV exposure or chronic wounding can cause sleeping cells to harbor the mutations which cause skin cancers such as basal cell carcinoma, a very aggressive type of skin cancer.

"The stem cells can harbor mutations throughout the years, but with no effect if they're still in sleep mode," explains Dr. Li. "However, when they start to divide to heal a wound for example, this could trigger the cancer. If it's possible to study this phenomenon for long periods of time it may be possible to find ways to prevent the activation of mutated cells and therefore reduce the risk of developing the disease."

Other parts of the body, such as the lung or gut lining and the cornea, also regenerate in the same way as our skin. Research is already underway at the University of Sheffield to look at the healing process of the lung lining following asthma attacks.

This study is an excellent example of how computer modelling can enhance our long-term understanding of complex processes such as skin aging. Dr. Upadhyay, a physicist-turned-computational biologist, drew inspiration from the great physicist Richard Feynman in summarizing the study, noting that, "You really don't understand something until you have built it from scratch. By building the virtual skin model from a few cells into a tissue capable of self-renewal, we have moved a big step in our understanding of stem cells and skin renewal."

Skin Stem Cell Hypotheses and Long Term Clone Survival – Explored Using Agent-based Modelling X. Li, A. K. Upadhyay, A. J. Bullock, T. Dicolandrea, J. Xu, R. L. Binder, M. K. Robinson, D. R. Finlay, K. J. Mills, C. C. Bascom, C. K. Kelling, R. J. Isfort, J. W. Haycock, S. MacNeil & R. H. Smallwood Scientific Reports 3, Article number: 1904 doi:10.1038/srep01904

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...